César A. Briceño, M.D.

faculty photo
Associate Professor of Clinical Ophthalmology
Assistant Professor of Ophthalmology, Perelman School of Medicine University of Michigan
Attending Physician , Penn Presbyterian Medical Center
Attending Physician , Hospital of the University of Pennsylvania
Consultant, Children’s Hospital of Philadelphia
Attending Physician, Corporal Michael J. Crescenz Veterans Administration Medical Center, Philadelphia, PA
Volunteer Attending Physician, Puentes de Salud Clinic, Philadelphia, PA
Co-Director of the Thyroid Eye Disease Program, Scheie Eye Institute
Advisory Dean, Perelman School of Medicine, University of Pennsylvania
Medical Director, Scheie Eye Institute at Penn Presbyterian Medical Center
Assistant Dean for Diversity and Cultural Affairs, Perelman School of Medicine, University of Pennsylvania
Department: Ophthalmology

Contact information
Scheie Eye Institute
51 N. 39th Street
Philadelphia, PA 19104
Office: (215) 662-9804
AB (Biology)
Harvard University, 2001.
Johns Hopkins University, 2007.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Dr. Briceño is a specialist in ophthalmic plastic surgery, a field that involves aesthetic and reconstructive surgery of the eyelids, eye socket (orbit), and tear duct system. He has special expertise thyroid eye disease, orbital trauma and reconstructive surgery of the eyelids and upper face. He also has expertise in cosmetic eyelid, brow and midface surgery and minimally invasive cosmetic procedures such as Botox injections and fillers.

Description of Other Expertise

Dr. Briceño is a nationally recognized leader in issues of diversity, equity and inclusion in ophthalmology. He has spoken nationally on the measurement and mitigation of Implicit bias and the mitigation of health disparities affecting LGBTQ+ persons. He serves as the assistant dean for diversity and cultural affairs at the Perelman School of Medicine and his work has been recorgnized by the American Academy of Ophthalmology with the Secretariat and Achievement awards.

Description of Research Expertise

Dr. Briceño is interested in studying surgical outcomes and health disparities in cutaneous malignancies of the periocular region as well as thyroid eye disease.

Key Words
Thyroid eye disease, orbit, eyelid, ptosis, blepharoplasty, ectropion, entropion, trichiasis, nasolacrimal duct obstruction, orbital fracture, orbital tumors, tear duct problems, trauma, chalazion, filler, botulinum

Selected Publications

Shivani Gupta, César A Briceño, Christine C Nelson, Raymond S Douglas: Customized Minimally Invasive Orbital Decompression for Thyroid Eye Disease. Expert Review of Ophthalmology October 2012.

César A Briceño, Shivani Gupta, Raymond S Douglas: Advances in the management of thyroid eye disease. Int Ophthalmol Clin 53(3): 93-101, Summer 2013.

César A Briceño CA, Sandy X Zhang-Nunes, Guy G Massry: Minimally invasive options for the brow and upper lid. Facial Plast Surg Clin North Am 23(2): 153-66, May 2015.

César A Briceño, Sandy X Zhang-Nunes, Guy G Massry: Minimally invasive surgical adjuncts to upper blepharoplasty. Facial Plast Surg Clin North Am 23(2): 137-51, May 2015.

César A Briceño, Guy G Massry : Chapter 10: Minimally Invasive Complementary Adjuncts to Upper Blepharoplasty. Master Techniques in Facial Rejuvenation, Second Edition Azizzadeh B, Murphy M, Johnson C, Massry GG (eds.). Elsevier Page: 107-119, 2018.

César A Briceño, Victor M Elner, Hakan Demirci: Lymphangiogenic and Chemotactic Factors in Conjunctival Melanoma. Ophthalmic Plast and Reconstr Surg 32(6): 428-433, November/December 2016.

Tiffany N Ballard, César A Briceño: Minocycline-induced orbital rim discoloration. J AAPOS 20(2): 182-4, April 2016.

Andi K Cani, Moaaz Soliman, Daniel H Hovelson, Chia-Jen Liu, Andrew S McDaniel, Michaela J Haller, Jarred V Bratley, Samantha E Rahrig, Qiang Li, César A Briceño, Scott A Tomlins, Rajesh C Rao: Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies. Mod Pathol 29(7): 685-697, July 2016.

back to top
Last updated: 04/04/2024
The Trustees of the University of Pennsylvania